GARO H ARMEN
CIK 935679 · See Remarks · last filed 2026-07-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.73M
Companies
5
Total Filings
272
Lifetime Open-Market Net
$7.86M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AGEN | See Remarks | 402,406 | $6.60 | $2.66M | $7.81M | 258 | 2026-07-14 |
| Protagenic Therapeutics, Inc.\new (PTIXW) Delisted | Executive Chairman | — | $0.01 | — | $0 | 1 | 2024-03-29 |
| INKT | Director | 196,640 | $10.54 | $2.07M | $0 | 4 | 2023-05-26 |
| AGENUS INC (AGEND) Delisted | Chairman & CEO | 1,746,471 | — | — | $49.8K | 1 | 2011-10-03 |
| COLOR KINETICS INC (CLRK) Delisted | Director | 0 | — | — | $0 | 4 | 2007-08-27 |
Recent Filings · Page 7 of 28
272 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-08 | AGEN | Grant (A) | +32,697 | $16.3K | EDGAR |
| 2024-03-29 | Protagenic Therapeutics, Inc.\new (PTIXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-25 | AGEN | Grant (A) | +27,163 | $14.9K | EDGAR |
| 2024-03-11 | AGEN | Grant (A) | +22,136 | $14.8K | EDGAR |
| 2024-02-27 | AGEN | Grant (A) | +21,815 | $14.8K | EDGAR |
| 2024-02-15 | AGEN | Buy (P) | +500,000 | $324.1K | EDGAR |
| 2024-02-12 | AGEN | Grant (A) | +19,778 | $14.8K | EDGAR |
| 2024-01-29 | AGEN | Grant (A) | +22,475 | $14.8K | EDGAR |
| 2024-01-16 | AGEN | Grant (A) | +23,177 | $14.8K | EDGAR |
| 2024-01-03 | AGEN | Grant (A) | +23,453 | $19.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.